Liang YX - Search Results

1

Tumor Suppressor Role and Clinical Significance of the FEV Gene in Prostate Cancer.

Liang YX, Liang YK, Zou ZH, Zhuo YJ, Ye JH, Zhu XJ, Cai ZD, Lin ZY, Mo RJ, Wu SL, Zhang YQ, Zhong WD. Liang YX, et al. Among authors: liang yk. Dis Markers. 2022 May 2;2022:8724035. doi: 10.1155/2022/8724035. eCollection 2022. Dis Markers. 2022. PMID: 35548776 Free PMC article.

2

[Analysis of HPLC of isomers of nitrotoluene and nitrobenzoic acid].

Liang Y, Yi Z, Cai Z, Zhu G. Liang Y, et al. Se Pu. 1999 Jul;17(4):397-8. Se Pu. 1999. PMID: 12552863 Chinese.

3

Protective effect of ganoderan on renal damage in rats with chronic glomerulonephritis.

Zhong WD, He HC, Ou RB, Bi XC, Dai QS, Han ZD, Liang YX, Ye YK, Qin WJ, Li Z, Zeng GH, Zhu G. Zhong WD, et al. Among authors: liang yx. Clin Invest Med. 2008;31(4):E212-7. doi: 10.25011/cim.v31i4.4782. Clin Invest Med. 2008. PMID: 18682045

4

CD147, MMP-1, MMP-2 and MMP-9 protein expression as significant prognostic factors in human prostate cancer.

Zhong WD, Han ZD, He HC, Bi XC, Dai QS, Zhu G, Ye YK, Liang YX, Qin WJ, Zhang Z, Zeng GH, Chen ZN. Zhong WD, et al. Among authors: liang yx. Oncology. 2008;75(3-4):230-6. doi: 10.1159/000163852. Epub 2008 Oct 14. Oncology. 2008. PMID: 18852494

5

Real-time quantitative RT-PCR assessment of PIM-1 and hK2 mRNA expression in benign prostate hyperplasia and prostate cancer.

He HC, Bi XC, Zheng ZW, Dai QS, Han ZD, Liang YX, Ye YK, Zeng GH, Zhu G, Zhong WD. He HC, et al. Among authors: liang yx. Med Oncol. 2009;26(3):303-8. doi: 10.1007/s12032-008-9120-9. Epub 2008 Nov 12. Med Oncol. 2009. PMID: 19003546

6

CD147 expression indicates unfavourable prognosis in prostate cancer.

Han ZD, Bi XC, Qin WJ, He HC, Dai QS, Zou J, Ye YK, Liang YX, Zeng GH, Chen ZN, Zhong WD. Han ZD, et al. Among authors: liang yx. Pathol Oncol Res. 2009 Sep;15(3):369-74. doi: 10.1007/s12253-008-9131-z. Pathol Oncol Res. 2009. PMID: 19048397 Free article.

7

Expression and clinical significance of CD147 in genitourinary carcinomas.

Han ZD, He HC, Bi XC, Qin WJ, Dai QS, Zou J, Ye YK, Liang YX, Zeng GH, Zhu G, Chen ZN, Zhong WD. Han ZD, et al. Among authors: liang yx. J Surg Res. 2010 May 15;160(2):260-7. doi: 10.1016/j.jss.2008.11.838. Epub 2008 Dec 10. J Surg Res. 2010. PMID: 19286191

8

Protective effect of glycyrrhizin on nephrotic syndrome induced by adriamycin in rats.

Bi X, Zhu G, Han Z, Ye Y, Liang Y, Zhang L, Hao Z, Zeng G, He H, Zhong W. Bi X, et al. Clin Invest Med. 2009 Jun 1;32(3):E229-38. Clin Invest Med. 2009. PMID: 19480741

9

CD147 and VEGF expression in advanced renal cell carcinoma and their prognostic value.

Liang YX, He HC, Han ZD, Bi XC, Dai QS, Ye YK, Qin WJ, Zeng GH, Zhu G, Xu CL, Zhong WD. Liang YX, et al. Cancer Invest. 2009 Aug;27(7):788-93. doi: 10.1080/07357900802709167. Cancer Invest. 2009. PMID: 19548138

10

Inhibition of proliferation, invasion, and migration of prostate cancer cells by downregulating elongation factor-1alpha expression.

Zhu G, Yan W, He HC, Bi XC, Han ZD, Dai QS, Ye YK, Liang YX, Wang J, Zhong W. Zhu G, et al. Among authors: liang yx. Mol Med. 2009 Nov-Dec;15(11-12):363-70. doi: 10.2119/molmed.2009.00082. Epub 2009 Aug 18. Mol Med. 2009. PMID: 19707524 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

261 results

Search Page